Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.

Publication ,  Journal Article
Harskamp, RE; Alexander, JH; Lopes, RD
Published in: Eur J Intern Med
July 2019

Duke Scholars

Published In

Eur J Intern Med

DOI

EISSN

1879-0828

Publication Date

July 2019

Volume

65

Start / End Page

4 / 5

Location

Netherlands

Related Subject Headings

  • Stroke
  • Randomized Controlled Trials as Topic
  • Platelet Aggregation Inhibitors
  • Percutaneous Coronary Intervention
  • Humans
  • Hematologic Agents
  • General & Internal Medicine
  • Fibrinolytic Agents
  • Drug Therapy, Combination
  • Coronary Artery Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Harskamp, R. E., Alexander, J. H., & Lopes, R. D. (2019). Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS. Eur J Intern Med, 65, 4–5. https://doi.org/10.1016/j.ejim.2019.05.018
Harskamp, Ralf E., John H. Alexander, and Renato D. Lopes. “Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.Eur J Intern Med 65 (July 2019): 4–5. https://doi.org/10.1016/j.ejim.2019.05.018.
Harskamp, Ralf E., et al. “Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.Eur J Intern Med, vol. 65, July 2019, pp. 4–5. Pubmed, doi:10.1016/j.ejim.2019.05.018.
Journal cover image

Published In

Eur J Intern Med

DOI

EISSN

1879-0828

Publication Date

July 2019

Volume

65

Start / End Page

4 / 5

Location

Netherlands

Related Subject Headings

  • Stroke
  • Randomized Controlled Trials as Topic
  • Platelet Aggregation Inhibitors
  • Percutaneous Coronary Intervention
  • Humans
  • Hematologic Agents
  • General & Internal Medicine
  • Fibrinolytic Agents
  • Drug Therapy, Combination
  • Coronary Artery Disease